Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Voss

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Journal of Virology|August 6, 2010
Virulence determinants of avian H5N1 influenza A virus in mammalian and avian hosts: role of the C-terminal ESEV motif in the viral NS1 proteinFlorian Zielecki, Ilia Semmler, Donata Kalthoff, et al.
Free Radical Biology & Medicine|August 16, 2017
Bcl-x<sub>L</sub> knockout attenuates mitochondrial respiration and causes oxidative stress that is compensated by pentose phosphate pathway activityAnnika Pfeiffer, Julia Schneider, Diones Bueno, et al.
Cells|May 28, 2022
Murine RAW Macrophages Are a Suitable Model to Study the CD3 Signaling in Myeloid CellsRanferi Ocaña-Guzmán, Lucero A Ramón-Luing, Michelle Rodríguez-Alvarado, et al.
Plos Neglected Tropical Diseases|December 8, 2017
A thermostable messenger RNA based vaccine against rabiesLothar Stitz, Annette Vogel, Margit Schnee, et al.
EMBO Reports|June 26, 2026
C-terminal lysine residues localise NLRP10 at lipid droplets and govern NLRP10 oligomer formationTimo-Daniel Voss, Christoph Winterberg, Adrian Beck, et al.
Nature Biotechnology|November 20, 2012
Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infectionBenjamin Petsch, Margit Schnee, Annette B Vogel, et al.
Vaccine|April 16, 2009
Development of a live-attenuated influenza B DeltaNS1 intranasal vaccine candidateNina Wressnigg, Daniel Voss, Thorsten Wolff, et al.
Virology Journal|January 19, 2010
Human coronavirus NL63 open reading frame 3 encodes a virion-incorporated N-glycosylated membrane proteinMarcel A Müller, Lia van der Hoek, Daniel Voss, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Virology|August 6, 2010
Virulence determinants of avian H5N1 influenza A virus in mammalian and avian hosts: role of the C-terminal ESEV motif in the viral NS1 proteinFlorian Zielecki, Ilia Semmler, Donata Kalthoff, et al.
Free Radical Biology & Medicine|August 16, 2017
Bcl-x<sub>L</sub> knockout attenuates mitochondrial respiration and causes oxidative stress that is compensated by pentose phosphate pathway activityAnnika Pfeiffer, Julia Schneider, Diones Bueno, et al.
Cells|May 28, 2022
Murine RAW Macrophages Are a Suitable Model to Study the CD3 Signaling in Myeloid CellsRanferi Ocaña-Guzmán, Lucero A Ramón-Luing, Michelle Rodríguez-Alvarado, et al.
Plos Neglected Tropical Diseases|December 8, 2017
A thermostable messenger RNA based vaccine against rabiesLothar Stitz, Annette Vogel, Margit Schnee, et al.
EMBO Reports|June 26, 2026
C-terminal lysine residues localise NLRP10 at lipid droplets and govern NLRP10 oligomer formationTimo-Daniel Voss, Christoph Winterberg, Adrian Beck, et al.
Nature Biotechnology|November 20, 2012
Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infectionBenjamin Petsch, Margit Schnee, Annette B Vogel, et al.
Vaccine|April 16, 2009
Development of a live-attenuated influenza B DeltaNS1 intranasal vaccine candidateNina Wressnigg, Daniel Voss, Thorsten Wolff, et al.
Virology Journal|January 19, 2010
Human coronavirus NL63 open reading frame 3 encodes a virion-incorporated N-glycosylated membrane proteinMarcel A Müller, Lia van der Hoek, Daniel Voss, et al.
Pageof 2